rct
    2020
    High Quality

    Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression

    Acevedo-Diaz EE, Cavanaugh GW, Greenstein D

    Published in Journal of Affective Disorders

    Methodology

    Analysis of adverse events from randomized, placebo-controlled ketamine infusion trials.

    Key Findings

    Dissociative symptoms were common but transient, resolving within hours of infusion.

    Conclusions

    Substance-induced dissociation is typically dose-related and time-limited.

    Limitations

    Single-dose data only.

    Related Health Concerns

    Dissociation
    Depression

    Study Details

    Year:2020
    Sample Size:163
    Duration:1 weeks
    Quality Score:7/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.